Lakeshore Biopharma CO (LSBCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 581 | 411 | 234 | 0 | 203 |
| Operating Income | -581 | -411 | -234 | N/A | -203 |
| Other Income | 6,287 | 2,131 | 7,361 | 0 | 1,238 |
| Pre-tax Income | 5,705 | 1,720 | 7,127 | 0 | 1,035 |
| Net Income Continuous | 5,705 | 1,720 | 7,127 | N/A | 1,035 |
| Net Income | $5,705 | $1,720 | $7,127 | $N/A | $1,035 |
| EPS Basic Total Ops | 2.20 | 0.70 | 2.80 | N/A | 0.40 |
| EPS Basic Continuous Ops | 9.92 | 2.99 | 12.39 | N/A | 1.80 |
| EPS Diluted Total Ops | 2.20 | 0.70 | 2.80 | N/A | 0.40 |
| EPS Diluted Continuous Ops | 9.92 | 2.99 | 12.39 | N/A | 1.80 |
| EBITDA(a) | $-581 | $-411 | $-234 | $N/A | $-203 |